(Sharecast News) - Smith & Nephew reported robust results for the first half of 2025 on Tuesday, with revenue, profit and cash generation all improving significantly, and unveiled plans for a $500m share buyback to return surplus capital to shareholders.
The FTSE 100 medical technology firm posted revenue of $2.96bn for...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE